Private Equity & Venture Capital | CCC Interim Leadership – MedTech & Life Sciences
Interim leadership for investor-backed MedTech, Medical Devices and Life Sciences companies
Operational stabilisation, scaling and transparent execution in critical phases
Investor-backed MedTech, Medical Devices and Life Sciences companies are often under significant pressure – following a deal, after a funding round, during a turnaround or in a critical growth phase. In these situations, it is not the investment thesis itself, but its operational execution that determines value creation, trust and exit readiness.
CCC Interim Leadership provides interim leadership where experienced, execution-focused leadership is required at short notice – with a clear focus on stabilisation, structure and measurable operational results.
The term investor-backed companies includes both Private Equity and Venture Capital financed organisations. In the MedTech and Life Sciences environment, Private Equity typically invests in established companies, while Venture Capital more often supports younger, technology-driven or rapidly growing organisations. In both situations, experienced leadership is required in critical phases to ensure stability, enable scaling and secure reliable operational execution.
My role in an investor-backed context
I take on strategic and operational leadership responsibility in Private Equity-backed, Venture Capital-backed and other investor-backed MedTech, Medical Devices and Life Sciences companies when internal management capacity is insufficient or transition situations require clarity and direction.
My contribution is not deal execution, but interim leadership after the deal or after funding:
- Safeguarding ongoing business performance
- Ensuring transparency and reliability for investors, boards and shareholders
- Building robust structures for scaling, growth and exit readiness
···
Typical engagement situations where I add value
Post-deal / post-funding stabilisation & operational interim leadership
After closing or after a funding round, I assume operational responsibility, create orientation and ensure the organisation remains fully capable of execution.
Key focus areas:
- Stabilising revenue, customer relationships and delivery capability
- Establishing clear leadership, decision-making and governance structures
- Structured, transparent communication with investors and governance bodies
···
Carve-outs, portfolio transitions & organisational build-up
In business units separated from larger structures, in portfolio companies or in rapidly growing VC-backed organisations, my focus is on operational stability and the establishment of robust structures.
Core responsibilities:
- Stabilising revenue streams and customer relationships
- Building independent organisations with clear roles and accountability
- Implementing investor-ready steering and reporting frameworks
···
Scaling, growth and value creation phases
- Structuring growth without operational overload
- Sharpening go-to-market, commercial and operating models
- Implementing robust KPI and reporting systems
- Preparing the organisation for the next funding round, ownership phase or exit
Industry focus
- MedTech & Medical Devices
- Life Sciences & adjacent services
- Healthcare-related technologies with a strong industrial foundation
I work exclusively in sectors where regulatory requirements, market dynamics and operational reality must be fully understood – and where interim leadership delivers impact in day-to-day execution.
Approach & expectations
Impact does not come from standard solutions, but from:
- Clear prioritisation instead of actionism
- Structured 90-/100-day agendas
- Methodical execution across defined impact areas
- Leadership with clarity, integrity and accountability
The objective is always an organisation that remains independently effective after the interim mandate.